BioLine RX Ltd
TASE:BLRX
Cash Flow Statement
Cash Flow Statement
BioLine RX Ltd
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Net Income |
(17)
|
(16)
|
(15)
|
(11)
|
(11)
|
(13)
|
(14)
|
(15)
|
(14)
|
(14)
|
(13)
|
(15)
|
(16)
|
(17)
|
(18)
|
(21)
|
(24)
|
(26)
|
(26)
|
(25)
|
(23)
|
(23)
|
(24)
|
(21)
|
(25)
|
(26)
|
(27)
|
(28)
|
(30)
|
(34)
|
(34)
|
(35)
|
(27)
|
(22)
|
(22)
|
(24)
|
(25)
|
(32)
|
(43)
|
(52)
|
(61)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
Other Non-Cash Items |
1
|
2
|
2
|
(3)
|
(5)
|
(3)
|
(2)
|
(1)
|
(0)
|
(1)
|
(2)
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
(0)
|
0
|
(0)
|
(4)
|
(2)
|
(3)
|
(1)
|
2
|
7
|
12
|
12
|
11
|
3
|
(3)
|
(3)
|
(4)
|
(3)
|
1
|
11
|
17
|
21
|
|
Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
1
|
1
|
1
|
1
|
|
Change in Working Capital |
(3)
|
(4)
|
(3)
|
(1)
|
0
|
0
|
1
|
(0)
|
0
|
(1)
|
(1)
|
1
|
0
|
2
|
2
|
2
|
3
|
1
|
(1)
|
(2)
|
(2)
|
0
|
1
|
2
|
4
|
3
|
3
|
2
|
(1)
|
(2)
|
(3)
|
(1)
|
(1)
|
1
|
3
|
1
|
1
|
1
|
(0)
|
2
|
15
|
|
Cash from Operating Activities |
(20)
N/A
|
(18)
+9%
|
(16)
+10%
|
(15)
+5%
|
(16)
-4%
|
(16)
-1%
|
(15)
+4%
|
(16)
-4%
|
(14)
+10%
|
(15)
-5%
|
(14)
+3%
|
(14)
+6%
|
(15)
-7%
|
(14)
+3%
|
(15)
-7%
|
(18)
-21%
|
(21)
-12%
|
(24)
-15%
|
(26)
-9%
|
(25)
+1%
|
(24)
+5%
|
(22)
+9%
|
(22)
-1%
|
(22)
-1%
|
(23)
-1%
|
(25)
-12%
|
(24)
+6%
|
(23)
+3%
|
(23)
0%
|
(22)
+4%
|
(24)
-8%
|
(24)
+2%
|
(24)
0%
|
(23)
+3%
|
(22)
+2%
|
(26)
-16%
|
(26)
-1%
|
(29)
-9%
|
(32)
-12%
|
(33)
-4%
|
(23)
+32%
|
|
Investing Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(3)
|
(3)
|
(3)
|
(1)
|
(0)
|
(0)
|
(4)
|
(4)
|
(4)
|
(4)
|
(1)
|
(1)
|
(1)
|
(10)
|
(10)
|
(10)
|
(10)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
|
Other Items |
(5)
|
(13)
|
(15)
|
(16)
|
(20)
|
(21)
|
(20)
|
(20)
|
(13)
|
9
|
8
|
11
|
9
|
13
|
(7)
|
(14)
|
(12)
|
(9)
|
11
|
20
|
20
|
2
|
6
|
6
|
5
|
21
|
9
|
11
|
17
|
(26)
|
(26)
|
(34)
|
(38)
|
3
|
19
|
4
|
4
|
6
|
7
|
26
|
2
|
|
Cash from Investing Activities |
(6)
N/A
|
(13)
-131%
|
(15)
-19%
|
(16)
-8%
|
(20)
-21%
|
(21)
-8%
|
(22)
-4%
|
(23)
-3%
|
(16)
+32%
|
7
N/A
|
6
-4%
|
10
+61%
|
9
-11%
|
9
-3%
|
(11)
N/A
|
(18)
-61%
|
(16)
+9%
|
(9)
+42%
|
11
N/A
|
20
+81%
|
10
-51%
|
(8)
N/A
|
(4)
+45%
|
(4)
-1%
|
5
N/A
|
21
+295%
|
9
-57%
|
11
+26%
|
17
+47%
|
(26)
N/A
|
(26)
-2%
|
(34)
-29%
|
(38)
-13%
|
3
N/A
|
19
+520%
|
4
-78%
|
4
-3%
|
6
+40%
|
7
+19%
|
26
+285%
|
1
-94%
|
|
Financing Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Net Issuance of Common Stock |
15
|
27
|
25
|
24
|
33
|
36
|
39
|
39
|
29
|
4
|
2
|
2
|
2
|
3
|
29
|
38
|
39
|
38
|
13
|
4
|
4
|
17
|
17
|
18
|
20
|
6
|
18
|
17
|
21
|
63
|
66
|
68
|
61
|
19
|
4
|
15
|
14
|
0
|
14
|
4
|
17
|
|
Net Issuance of Debt |
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
9
|
9
|
9
|
9
|
(1)
|
(2)
|
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(4)
|
(4)
|
(4)
|
5
|
6
|
7
|
8
|
(1)
|
(2)
|
|
Other |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
Cash from Financing Activities |
15
N/A
|
27
+73%
|
25
-5%
|
24
-5%
|
33
+35%
|
36
+12%
|
39
+6%
|
39
+2%
|
29
-25%
|
5
-84%
|
2
-48%
|
2
-28%
|
2
+22%
|
3
+23%
|
29
+1 017%
|
38
+33%
|
39
+1%
|
38
-2%
|
13
-65%
|
4
-71%
|
13
+244%
|
27
+103%
|
26
-2%
|
27
+3%
|
19
-29%
|
5
-76%
|
15
+231%
|
14
-12%
|
18
+32%
|
59
+232%
|
62
+4%
|
65
+4%
|
58
-10%
|
15
-74%
|
0
-99%
|
21
+18 070%
|
20
-4%
|
21
+4%
|
22
+3%
|
3
-88%
|
15
+464%
|
|
Change in Cash | ||||||||||||||||||||||||||||||||||||||||||
Effect of Foreign Exchange Rates |
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
|
Net Change in Cash |
(10)
N/A
|
(4)
+59%
|
(6)
-39%
|
(8)
-28%
|
(3)
+59%
|
(1)
+65%
|
1
N/A
|
1
-38%
|
(0)
N/A
|
(3)
-1 319%
|
(6)
-59%
|
(1)
+76%
|
(3)
-135%
|
(2)
+23%
|
3
N/A
|
3
-12%
|
3
-3%
|
6
+112%
|
(1)
N/A
|
(2)
-74%
|
(2)
+15%
|
(3)
-100%
|
(1)
+76%
|
0
N/A
|
2
+940%
|
0
-91%
|
1
+228%
|
2
+203%
|
12
+592%
|
11
0%
|
12
+4%
|
8
-37%
|
(4)
N/A
|
(5)
-20%
|
(3)
+24%
|
(1)
+72%
|
(2)
-147%
|
(2)
+1%
|
(4)
-64%
|
(5)
-38%
|
(6)
-18%
|
|
Free Cash Flow | ||||||||||||||||||||||||||||||||||||||||||
Free Cash Flow |
(20)
N/A
|
(18)
+9%
|
(16)
+10%
|
(15)
+5%
|
(16)
-4%
|
(16)
-1%
|
(17)
-5%
|
(18)
-8%
|
(17)
+8%
|
(18)
-4%
|
(16)
+10%
|
(14)
+11%
|
(15)
-4%
|
(18)
-22%
|
(19)
-5%
|
(22)
-17%
|
(25)
-13%
|
(24)
+3%
|
(26)
-8%
|
(26)
+1%
|
(34)
-33%
|
(32)
+7%
|
(32)
-1%
|
(33)
0%
|
(23)
+30%
|
(25)
-11%
|
(24)
+6%
|
(23)
+3%
|
(23)
+0%
|
(22)
+4%
|
(24)
-8%
|
(24)
+2%
|
(24)
-1%
|
(23)
+3%
|
(23)
+2%
|
(26)
-16%
|
(27)
-1%
|
(29)
-10%
|
(33)
-12%
|
(34)
-4%
|
(23)
+32%
|